The SELECT trial, published in the New England Journal of Medicine in 2023, showed that semaglutide reduced major adverse cardiovascular events by 20% in patients with obesity and established cardiovascular disease
the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed
The manufacturing requires specialized facilities, extensive quality control, and sophisticated cold-chain logistics for distribution
Cases were claimed to be successfully cured with antibiotics and dietary changes as above
9 The current advantages, research stage and areas of opportunity of small molecule GLP-1RAs is summarized in Figure 3
VEGF, in particular, is a potent driver of malignant angiogenesis and metastasis (110)